Trial NCT03191981

View at ClinicalTrials.gov 
Org. Study IDs: HM16/87650

Last trial update was posted on 2017-08-24

MeSH Interventions

Cyclophosphamide Lenalidomide Pembrolizumab

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Myeloma Multiple

Stopping Reasons

Withdrawal of pharma support prior to opening to recruitment

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID